拉米夫定与单磷酸阿糖腺苷联合应用抗-HBV的体外实验研究

来源 :中华实验和临床病毒学杂志 | 被引量 : 0次 | 上传用户:tlhcm
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 体外观察拉米夫定 (3TC)与单磷酸阿糖腺苷 (Ara AMP)联合应用的抗 HBV作用。方法 以 2 2 15细胞为靶细胞 ,实验共进行 8d。采用放射免疫法及斑点杂交测定单用 3TC、Ara AMP及联合应用后对培养上清液HBsAg、HBeAg及细胞内HBVDNA的抑制作用。结果 Ara AMP浓度为40 0 0 μg ml时 ,对HBsAg、HBeAg的抑制作用分别为 45 48%和 41 46 %。 3TC在所取浓度范围内虽然对HBsAg和HBeAg也有一定的抑制作用 ,但抑制作用较弱。Ara AMP 5 0 0 μg ml与 3TC 1 2 5和 5 0 0μg ml联合应用 ,对HBsAg的抑制率分别可达 19 92 %和 17 32 %。其HBsAg含量与单用相同浓度的3TC相比 ,差异有显著意义 (P <0 0 5 ) ,但与单用相同浓度的Ara AMP相比 ,差异无显著意义 (P <0 0 5 )。联合用药对HBeAg无明显抑制作用。 3TC 5 0 0 μg ml与Ara AMP 12 5和 5 0 0 μg ml联合应用 ,对HBVDNA抑制率可达 45 90 %和 5 0 36 %。HBVDNA含量与阴性对照组及单用相同浓度的 3TC、Ara AMP组相比 ,差异有显著意义 (P <0 0 5 )。结论  3TC与Ara AMP联合应用对HBVDNA的抑制作用明显增强 Objective To observe the anti-HBV effect of lamivudine (3TC) in combination with Ara AMP. Methods 2 2 15 cells as target cells, the experiment for a total of 8d. The inhibition of HBsAg, HBeAg and intracellular HBVDNA in culture supernatant was determined by radioimmunoassay and dot blot hybridization with 3TC, Ara AMP alone and in combination. Results When the concentration of Ara AMP was 40 0 ​​0 μg ml, the inhibitory effects on HBsAg and HBeAg were 45 48% and 41 46%, respectively. 3TC in the concentration range although the HBsAg and HBeAg also have some inhibition, but the inhibition is weak. Ara AMP 5 0 0 μg ml in combination with 3TC 1 2 5 and 500 μg ml inhibited HBsAg up to 19 92% and 17 32%, respectively. The difference was significant (P <0.05) when compared with the same concentration of 3TC alone, but there was no significant difference (P <0.05) with the same concentration of Ara AMP alone. Combination of HBeAg no significant inhibitory effect. The combination of 3TC 500 μg ml with Ara AMP 12 5 and 500 μg ml inhibited the HBVDNA up to 45 90% and 50 36%. Compared with the negative control group and the same concentration of 3TC, Ara AMP group, the level of HBVDNA was significantly different (P <0.05). Conclusion 3TC and Ara AMP combined with HBVDNA significantly inhibited the inhibitory effect
其他文献
目的观察血管紧张素转换酶抑制剂(ACEI)——苯那普利对幼龄肾硬化大鼠的保护作用,并探讨其调节肾小球细胞外基质(ECM)积聚的作用机制。方法将16只SD幼龄大鼠(1个月龄,体重100 g左右)分为3组:(1)正常对照组(5只);(2)模型组(6只);(3)治疗组(5只)。对大鼠行单侧肾切除1周后加阿霉素(5 mg/kg)注射建立肾硬化模型,术后即对治疗组给予苯那普利6 mg/(kg·d),共12周